The Forum for Collaborative HIV Research - David Evans joins Forum EC as ATAC Representative

In This Section

Announcements

CDC Update to Interim Guidance for PrEP: PrEP for Injecting Drug Users

JUN-13-13 The Thailand Ministry of Health and CDC published results from a randomized controlled trial of a daily oral dose of 300 mg of tenofovir disoproxil fumarate (TDF) that showed efficacy in reducing the acquisition of HIV infection among injecting drug users. Based on these findings, CDC recommends that preexposure prophylaxis (PrEP) be considered as one of several prevention options for persons at very high risk for HIV acquisition through the injection of illicit drugs. Click here to view the updated guidance in the MMWR and click here to view the Lancet article .

On Behalf of IDSA: Urge Lawmakers to Protect PEPFAR Funding

MAY-22-13 IDSA is asking for you to join them and lend your name to a letter in support of PEPFAR funding for the next fiscal year. Click here to read the letter and sign by Monday, June 3-Noon Eastern time.

Renewal of the National Viral Hepatitis Action Plan, 2014-2016

MAY-20-13 Dr. Ronald Valdiserri writes to recognize the second anniversary of Combating the Silent Epidemic of Viral Hepatitis: Action Plan for the Prevention, Care & Treatment of Viral Hepatitis and to share an important announcement from Dr. Howard Koh about plans to update and renew the existing plan through 2014-2016.

MAY-17-13 Please join the Forum in congratulating Nina Mani on an exciting new career move. Nina is leaving the Forum, but she is not going far – starting June 3 she will join the FDA Center for Drug Evaluation Research, Division of Antiviral Products. That we will miss her is the understatement of the century. But the offer to join our colleagues at the FDA as a project manager presented a phenomenal opportunity – an excellent fit for her career path. We congratulate Jeff, Kim, Jules and Patrick on an excellent choice! We imagine that many of you will have the pleasure of interacting with her in her new capacity.

National Viral Hepatitis Action Plan to Be Renewed

MAY-16-13 Dr. Howard Koh, the Assistant Secretary for Health, announced on May 16 that the partner agencies are committed and dedicated to renewing the Action Plan for another three years and are currently working on their vision and priorities for 2014-2016.

Upcoming Events

29-Jun-13

IAS 2013 Towards an HIV Cure Symposium

23-May-13

Hepatitis B and C Testing and Awareness Day in House of Representatives

Join Our Email Service

David Evans joins Forum EC as ATAC Representative

JAN-23-12 Director of Research Advocacy at Project Inform joins the Forum's Executive Committee. To learn more about David Evans, click here.

David Evans has been an HIV treatment advocate and educator since 1991, and is currently the Director of Research Advocacy for Project Inform, a non-profit HIV and viral hepatitis community-based information and advocacy organization. He co-developed on of the first HIV treatment educators certification programs in the United States in the mid-1990s, and has provided regular input to academic and industry researchers on HIV and hepatitis C clinical trial design. In addition to HIV and hepatitis treatment development, he is also focused on biomedical prevention for HIV, research and program development to improve linkage to and retention in health care for HIV-positive individuals and on advocate efforts to expand the workforce capacity of hepatitis C health care providers.